49Indexed trials
mesh condition
Migraine Disorders
Intelligence
Migraine Disorders intelligence: 49 indexed trials, 6 recruiting studies, 40 sponsors across 37 countries.
6Recruiting
40Sponsors
37Countries
Leading sponsors
Pfizer50 recruiting
AbbVie43 recruiting
Eli Lilly and Company20 recruiting
Allergan20 recruiting
Azienda Sanitaria Locale di Alessandria10 recruiting
Cefaly Technology10 recruiting
All India Institute of Medical Sciences10 recruiting
Duke University10 recruiting
Danish Headache Center10 recruiting
ElectroCore INC10 recruiting
Centre Hospitalier Universitaire de Nice11 recruiting
Amgen10 recruiting
Geographic activity
United States26trials
Belgium5trials
United Kingdom5trials
Italy5trials
Switzerland4trials
Spain4trials
France4trials
Netherlands4trials
Germany4trials
South Korea3trials
Japan3trials
Greece3trials
Leading interventions
Atogepant3trials
Transcranial direct current stimulation2trials
Zavegepant2trials
Acupuncture1trials
Anisodine Hydrobromide placebo1trials
Anisodine Hydrobromide1trials
CBT Individual Psychotherapy1trials
BOLD MRI1trials
CEFALY Active1trials
CEFALY Placebo1trials
Clinical interview/exam1trials
Amiloride1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.